• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Hamilton Lane Incorporated

    9/5/24 5:04:43 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    S-8 1 hlne-sx82024eip.htm S-8 Document


    As filed with the Securities and Exchange Commission on September 5, 2024
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    HAMILTON LANE INCORPORATED
    (Exact name of Registrant as specified in its charter)
    Delaware
    (State or other jurisdiction of
    incorporation or organization)
    26-2482738
    (I.R.S. Employer
    Identification No.)
    110 Washington Street, Suite 1300
    Conshohocken, PA 19428
    (610) 934-2222
    (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
    AMENDED AND RESTATED HAMILTON LANE INCORPORATED 2017 EQUITY INCENTIVE PLAN
    (Full title of the plan)
    Lydia A. Gavalis
    General Counsel and Secretary
    110 Washington Street, Suite 1300
    Conshohocken, PA 19428
    (610) 934-2222
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
    Copies to:
    Matthew H. Meyers
    Griffin D. Foster
    Faegre Drinker Biddle & Reath LLP
    One Logan Square, Suite 2000
    Philadelphia, PA 19103
    (215) 988-2700
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:
    Large accelerated filerxAccelerated filer o
    Non-accelerated fileroSmaller reporting companyo
    Emerging growth companyo
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o




    EXPLANATORY NOTE

    Pursuant to General Instruction E of Form S-8, this Registration Statement is filed to register an additional 5,000,000 shares of the Class A common stock, $0.001 par value (“Common Stock”), of Hamilton Lane Incorporated (the “Registrant”) reserved for issuance under the Amended and Restated Hamilton Lane Incorporated 2017 Equity Incentive Plan (the “Plan”). Shares of the Registrant’s Common Stock issuable under the Plan were initially registered pursuant to a Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on March 3, 2017 (No. 333-216443). Such Registration Statement is currently effective and the contents thereof are incorporated herein by reference except to the extent that such content is superseded by the items appearing below.

    PART I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The information specified in Part I of Form S-8 is omitted from this Registration Statement on Form S-8 in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the Note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the Plan covered by this Registration Statement as required by Rule 428(b)(1) under the Securities Act. Such documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II below, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3.
    Incorporation of Documents by Reference.

    The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed by the Registrant with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”):

    •the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed with the Commission on May 23, 2024;
    •the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, filed with the Commission on August 6, 2024;
    •the Registrant’s Current Reports on Form 8-K filed with the Commission on June 26, 2024 and September 5, 2024;
    •the information specifically incorporated by reference into the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2024 from the Registrant's Definitive Proxy Statement on Schedule 14A, filed with the Commission on July 25, 2024; and
    •the description of the Registrant’s Class A common stock contained in the Registrant’s Registration Statement on Form 8-A (Registration No. 001-38021) filed with the Commission on February 27, 2017, pursuant to Section 12(b) of the Exchange Act, including any amendments or reports filed for the purpose of updating such description.



    All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the effective date of this Registration Statement (except for any portions of the Registrant’s Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission) but prior to the filing of a post-effective amendment, which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.

    Any statement contained herein or in a document incorporated herein by reference shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document incorporated herein by reference modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part hereof.
    Item 4.
    Description of Securities.
    Not applicable.
    Item 5.
    Interests of Named Experts and Counsel.
    Not applicable.
    Item 6.
    Indemnification of Directors and Officers.
    Section 145 of the General Corporation Law of the State of Delaware (the “DGCL”) grants each corporation organized thereunder the power to indemnify any person who is or was a director, officer, employee or agent of a corporation or enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of being or having been in any such capacity, if he or she acted in good faith in a manner reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action, or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that with respect to an action brought by or in the right of the corporation such indemnification is limited to expenses (including attorneys’ fees). The Registrant’s amended and restated certificate of incorporation provides that it must indemnify its directors and officers to the fullest extent permitted by Delaware law. The Registrant has entered into indemnification agreements with each of its directors and officers that may, in some cases, be broader than the specific indemnification provisions contained under Delaware law.

    Section 102(b)(7) of the DGCL enables a corporation, in its certificate of incorporation or an amendment thereto, to eliminate or limit the personal liability of a director or officer to the corporation or its stockholders for monetary damages for violations of the director’s or officer’s fiduciary duty, except (i) for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the DGCL (providing for liability of directors for unlawful payment of dividends or unlawful stock purchases or redemptions), (iv) for any transaction from which a director or officer derived an improper personal benefit or (v) for any action against an officer by or in the right of the corporation. The Registrant’s Certificate of Incorporation provides for such limitations on liability for its directors and officers.

    The Registrant currently maintains liability insurance for its directors and officers.
    Item 7.
    Exemption From Registration Claimed.
    Not applicable.



    Item 8.
    Exhibits.

    See exhibits listed under Exhibit Index below.
    Item 9.
    Undertakings.
    (a) The undersigned Registrant hereby undertakes:

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement; and

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
    Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities



    (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


    Exhibit
    Number
    Description
    4.1
    Amended and Restated Hamilton Lane Incorporated 2017 Equity Incentive Plan (incorporated by reference to Appendix B of the Registrant’s Definitive Proxy Statement on Schedule 14A, filed on July 25, 2024 (file no. 001-38021))
    5.1*
    Opinion of Faegre Drinker Biddle & Reath LLP
    23.1*
    Consent of Ernst & Young LLP
    23.2*
    Consent of Faegre Drinker Biddle & Reath LLP (contained in Exhibit 5.1)
    24.1*
    Power of Attorney (included as part of the signature page to this Registration Statement)
    107*
    Filing Fee Table
    _________
    * Filed herewith








    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Conshohocken, Commonwealth of Pennsylvania, on September 5, 2024.

    HAMILTON LANE INCORPORATED
    By:/s/ Erik R. Hirsch
    Name: Erik R. Hirsch
    Title: Co-Chief Executive Officer


    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned directors and officers of Hamilton Lane Incorporated hereby severally constitutes and appoints Erik R. Hirsch, Juan Delgado-Moreira and Lydia A. Gavalis, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution for him or her in any and all capacities, to sign any and all amendments to this registration statement on Form S-8 and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact, or any substitute, may do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on the 5th day of September, 2024.





    SignatureTitle
    /s/ Hartley R. RogersExecutive Co-Chairman of the Board of Directors
    Hartley R. Rogers
    /s/ Mario L. GianniniExecutive Co-Chairman of the Board of Directors
    Mario L. Giannini
    /s/ Erik R. HirschCo-Chief Executive Officer and Director (Co-Principal Executive Officer)
    Erik R. Hirsch
    /s/ Juan Delgado-MoreiraCo-Chief Executive Officer and Director (Co-Principal Executive Officer)
    Juan Delgado-Moreira
    /s/ Jeffrey ArmbristerChief Financial Officer and Treasurer (Principal Financial Officer)
    Jeffrey Armbrister
    /s/ Drew T. CarlChief Accounting Officer (Principal Accounting Officer)
    Drew T. Carl
    /s/ David J. BerkmanDirector
    David J. Berkman
    /s/ R. Vann GravesDirector
    R. Vann Graves
    /s/ O. Griffith SextonDirector
    O. Griffith Sexton
    /s/ Leslie F. VaronDirector
    Leslie F. Varon

    Get the next $HLNE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    12/11/2025$166.00Buy
    UBS
    11/6/2025$165.00Neutral → Buy
    Goldman
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $HLNE
    SEC Filings

    View All

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 4:18:01 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    2/3/26 7:00:09 AM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    11/4/25 4:16:24 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    YCharts Introduces Hamilton Lane Benchmarks to Bring Private Markets Insights to Advisors

    New benchmarks from Hamilton Lane provide advisors with trusted data to evaluate private markets strategies and allocations. YCharts, a leading investment research and client engagement platform, today announced the introduction of benchmark data from leading global private markets investment firm Hamilton Lane (NASDAQ:HLNE). The addition brings new visibility into private markets, helping financial advisors benchmark private fund performance, evaluate portfolio diversification and explain the role of private markets in client strategies. With private markets playing an increasingly important role in client portfolios, advisors need a new set of tools to assess private investments with

    2/10/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Closes on Nearly $2 Billion in Infrastructure Opportunities Fund II and Related Vehicles, Tripling Size of Predecessor Fund

    IOF II closed on over $1.5 billion of capital commitments, with nearly $400 million of additional capital committed alongside the Fund in related vehicles, representing almost $2 billion in total commitmentsThe Fund and related vehicles are more than three times larger than predecessor vehicle and well exceeded its $1.25 billion targetCONSHOHOCKEN, Pa., Feb. 2, 2026 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the final closing of the Hamilton Lane Infrastructure Opportunities Fund II ("IOF II" or "the Fund"), with $1.5 billion closed in the Fund and another nearly $400 million invested alongside the Fund in related veh

    2/2/26 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Hamilton Lane with a new price target

    UBS resumed coverage of Hamilton Lane with a rating of Buy and set a new price target of $166.00

    12/11/25 9:09:19 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00

    11/6/25 8:41:24 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00

    10/14/25 8:37:36 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan gifted 14,375 shares and received a gift of 14,375 shares, increasing direct ownership by 1% to 1,328,822 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    2/9/26 4:35:09 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Hamilton Lane and Guardian Announce Long-Term Strategic Partnership

    CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a

    11/3/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Penn., Feb. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2025. The Company issued a full detailed presentation of its third quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on March 20, 2026 that will be paid on April 6, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    2/3/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Guardian unveils "The Year Ahead," revealing how 2026's major financial themes will shape Americans' financial future

    Inaugural report empowers individuals to navigate uncertainty, identify emerging opportunities, and plan holistically across their financial lives NEW YORK, Jan. 20, 2026 /PRNewswire/ -- As headlines and data often paint a conflicting economic picture, The Guardian Life Insurance Company of America® (Guardian) has issued Guardian Wealth Insights: The Year Ahead, an outlook designed to help Americans make sense of the financial opportunities and challenges in 2026. Read Guardian Wealth Insights: The Year Ahead here From navigating megatrends like inflation and regulatory change

    1/20/26 9:30:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Third Quarter Fiscal 2026 Results on February 3, 2026

    CONSHOHOCKEN, Pa., Jan. 13, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the third fiscal quarter ended December 31, 2025 before the market opens on Tuesday, February 3, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on February 3 to discuss the results for the third fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by  clicking here (https://shareholders.hamiltonlane.com/) at least

    1/13/26 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance